News

Saratoga Investment Corp. Set to Release Financial Insights Soon

Saratoga Investment Corp. Set to Release Financial Insights Soon

Saratoga Investment Corp. Announces Financial Results Timeline

Saratoga Investment Corp. (NYSE:SAR), a leading business development company, will soon unveil its financial results for the fiscal quarter concluding on November 30, 2024. This announcement is set for January 8, 2025, following the market's closing bell. The company invites stakeholders and interested parties to join a conference call scheduled for the following day, January 9, 2025, where key executives will delve into the details of the quarterly performance.

Details of the Conference Call

This conference call promises to be insightful, featuring prominent company leaders who will discuss the results. Included in the call will be Christian L. Oberbeck, the Chairman and Chief Executive Officer of Saratoga Investment Corp. Alongside him will be Michael J. Grisius, the Chief Investment Officer, and Henri J. Steenkamp, who serves as the Chief Financial Officer, Chief Compliance Officer, Treasurer, and Secretary.

Call Timing and Access

The call will commence at 10:00 a.m. Eastern Time (ET) on January 9, 2025. Interested participants can access the call through a dedicated webcast, which will be broadcast live. For those unable to attend in real-time, a replay will be made available for a limited period after the call.

How to Join the Conference Call

For those wishing to participate via phone, registration is required ahead of the call. Participants are encouraged to sign up in advance to receive the dial-in information and to join the call approximately fifteen minutes beforehand to ensure a smooth experience.

Understanding Saratoga Investment Corp.

Saratoga Investment Corp. specializes in providing customized financing solutions to middle-market businesses throughout the United States. By focusing primarily on senior and unitranche leveraged loans as well as mezzanine debt, the company facilitates a variety of financial activities including ownership changes, strategic acquisitions, and growth initiatives. This approach involves strong partnerships with business owners, management teams, and financial sponsors to enhance the chances of success.

Investment Strategy and Objectives

The core objective of Saratoga Investment is to create attractive risk-adjusted returns. The company aims for this by focusing on generating current income along with long-term capital appreciation from both its debt and equity investments. By electing to operate under the Investment Company Act of 1940 as a regulated business development company, Saratoga adheres to rigorous standards to ensure financial responsibility and accountability.

Current Operations and Financial Structure

Saratoga Investment Corp. is strategically positioned with a diverse range of funding sources. The company not only manages a substantial $600 million collateralized loan obligation (CLO) fund but also co-manages a joint venture fund currently valued at $400 million, which further enhances its investment capacity. With a robust capital base and active operational strategies, Saratoga Investment is well-equipped to offer an expansive range of financial solutions.

Contact Information

For more information regarding the upcoming financial results and opportunities for engagement, please reach out to:

Henri Steenkamp
Saratoga Investment Corp.
212-906-7800

Frequently Asked Questions

When are the financial results being announced?

The financial results for Saratoga Investment Corp. will be reported on January 8, 2025.

What is the purpose of the conference call?

The conference call will provide insights into the company’s fiscal performance during the quarter ended November 30, 2024.

Who will be participating in the conference call?

Key executives including Chairman Christian L. Oberbeck, CIO Michael J. Grisius, and CFO Henri J. Steenkamp will be present.

How can participants access the call?

Participants can join the call through a live webcast or by dialing in using the provided registration link.

What types of investments does Saratoga specialize in?

Saratoga focuses on senior and unitranche leveraged loans, mezzanine debt, and equity investments aimed at middle-market businesses.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Likang's Bold Move: Cancer Immunotherapy at AD Summit

Updated Category News Views 159

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 92

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 118

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 158

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 145

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 98

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 0

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
What to Expect: Your First Therapy Session Insights

Updated Category News Views 201

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 0

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 195

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading

Top 5 Most Recently Viewed Articles

Spruce Point's Strong Sell Rating Casts Doubt on Construction Partners

Updated Category News Views 116

Spruce Point's Strong Sell Opinion on Construction Partners Inc Spruce Point Capital Management has recently issued a compelling report regarding Construction Partners Inc (NASDAQ: ROAD), a company recognized for its expertise in infrastructure and road construction. This report voices a strong sell recommendation, reflecting serious concerns over the company's current...

Continue Reading
Celebrating Excellence in Healthcare: Press Ganey's Honorees

Updated Category News Views 344

Celebrating the Executive Human Experience Award Winners Press Ganey, an industry leader dedicated to enhancing healthcare experiences, recently celebrated exceptional achievements in the field. During its annual conference, the Executive Human Experience Awards recognized extraordinary contributions from professionals and organizations that prioritize patient, consumer,...

Continue Reading
Commercial Vehicle Market Growth Driven by Technology Advancements

Updated Category News Views 122

Commercial Vehicle Market Growth and Projections The global commercial vehicle market is on an upward trajectory, with sales expected to reach 3.5 million units by 2025. The anticipated Year-over-Year (YoY) growth of 4.4% from 2024 highlights the increasing demand for medium and heavy commercial vehicles. This trend is being driven by several factors, including...

Continue Reading
Atos Receives Prestigious EcoVadis Platinum Medal Again

Updated Category News Views 195

Let’s not beat around the bush—Atos is doing something right in the sustainability game. They've bagged the EcoVadis Platinum Medal for five years running. Yep, that’s a serious flex in today’s corporate climate where ‘green’ isn’t just a buzzword; it’s almost an obligation if you want to stay relevant. The Metrics Behind Atos's Shine Scoring a...

Continue Reading
Power Metallic Mines Updates Shareholder Meeting Outcomes

Updated Category News Views 157

Power Metallic Mines Reports on AGSM Meeting Outcomes Power Metallic Mines Inc. (the "Company" or "Power Metallic") (TSXV: PNPN) (OTCBB: PNPNF) expressed satisfaction with the voting outcomes from its Annual General and Special Meeting ("AGSM") that took place recently. The meeting gathered shareholders to discuss essential business items and elect members to the Board of...

Continue Reading